Shandong Linuo Pharmaceutical Packaging Co., Ltd. (SHE:301188)

SHE:301188 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	280.72	521.53	490.49	446.63	413.45	710.79
Trading Asset Securities	30	56.36	295.75	453.15	117.43	-
Cash & Short-Term Investments	310.72	577.88	786.24	899.78	530.88	710.79
Cash Growth	-37.45%	-26.50%	-12.62%	69.49%	-25.31%	1145.06%
Accounts Receivable	308.86	289.31	272.28	223.72	212.43	171.67
Other Receivables	6.89	8.03	9.53	14.99	2.44	0.35
Receivables	315.75	297.34	281.81	238.71	214.87	172.03
Inventory	548.42	457.53	272.69	204.67	165.3	118.38
Prepaid Expenses	-	-	-	0	1.26	-
Other Current Assets	99.39	64.47	37.76	12.56	23.07	20.3
Total Current Assets	1,274	1,397	1,379	1,356	935.37	1,021
Property, Plant & Equipment	1,128	985.53	819.91	646.96	595.25	447.86
Long-Term Investments	149.26	145.75	52.99	68.74	44.37	39.27
Other Intangible Assets	94.12	72.12	70.3	26.39	27.4	28.64
Long-Term Deferred Tax Assets	10.25	-	-	3.02	2.21	1.69
Long-Term Deferred Charges	26.02	27.7	1.46	5.36	4.85	6.38
Other Long-Term Assets	104.99	76.89	32.85	44.72	30.52	15.37
Total Assets	2,787	2,705	2,356	2,151	1,640	1,561

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	385.22	336.05	243.01	117.21	150.78	123.21
Accrued Expenses	14.43	16.83	17.27	16.45	14.38	13.05
Short-Term Debt	137.65	30.02	15.01	-	-	25
Current Portion of Long-Term Debt	36.96	1.58	0.89	0.54	-	-
Current Portion of Leases	-	2.81	0.74	0.35	0.33	0.48
Current Income Taxes Payable	5.11	7.31	5.91	4.88	-	3.78
Current Unearned Revenue	23.09	21.58	14.33	18.71	16.11	10.34
Other Current Liabilities	31.92	37.98	40.03	33.54	14.35	14.24
Total Current Liabilities	634.37	454.15	337.2	191.68	195.96	190.1
Long-Term Debt	105.56	584.73	394.48	371.05	-	-
Long-Term Leases	6.9	8.2	-	0.36	0.71	1.04
Long-Term Unearned Revenue	74.71	81.85	53.93	1.55	2.33	3.12
Long-Term Deferred Tax Liabilities	-	3.13	16.19	26.02	9.74	5.54
Total Liabilities	821.54	1,132	801.8	590.66	208.75	199.81

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	267.54	239.07	232.45	232.41	232.41	232.41
Additional Paid-In Capital	1,334	893.34	798.86	797.94	797.87	797.7
Retained Earnings	495.68	480.43	463.54	420.4	400.96	330.79
Treasury Stock	-131.15	-131.15	-50.03	-	-	-
Comprehensive Income & Other	-0.94	91.45	109.4	109.52	-	-
Shareholders' Equity	1,966	1,573	1,554	1,560	1,431	1,361
Total Liabilities & Equity	2,787	2,705	2,356	2,151	1,640	1,561

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	287.06	627.34	411.13	372.29	1.04	26.53
Net Cash (Debt)	23.65	-49.46	375.11	527.49	529.84	684.26
Net Cash Growth	-60.25%	-	-28.89%	-0.44%	-22.57%	2882.97%
Net Cash Per Share	0.09	-0.21	1.65	2.24	2.27	3.84
Filing Date Shares Outstanding	253.25	230.99	228.93	232.41	232.41	232.41
Total Common Shares Outstanding	253.25	230.99	228.93	232.41	232.41	232.41
Working Capital	639.9	943.07	1,041	1,164	739.41	831.39
Book Value Per Share	7.76	6.81	6.79	6.71	6.16	5.86
Tangible Book Value	1,871	1,501	1,484	1,534	1,404	1,332
Tangible Book Value Per Share	7.39	6.50	6.48	6.60	6.04	5.73
Buildings	-	382.13	377.41	348.96	340.3	227.66
Machinery	-	833.86	748.47	671.64	522.85	412.25
Construction In Progress	-	301.37	150.11	31.89	72.86	108.95

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error